Broadwood Capital Inc.
In its 13F for Q3 2025 (holdings as of September 30, 2025, filed November 14, 2025), Broadwood Capital Inc. reported 7 stock positions worth $1.7 billion. Its top holding was Monster Beverage (MNST) at 33.6% of the portfolio, followed by Axon Enterprise (AXON, 30.1%) and Staar Surgical (STAA, 22.0%). Compared with Q2 2025, it sold out of 1 and reduced 3. The biggest sale was Axon Enterprise (AXON, shares −0%).
- Most Recent 13F
- Q2 2026
- Location
- New York, NY
- CIK
- 0001278387
- Portfolio Value
- $1.7B (Q3 2025)
- SEC Filing
- 0000919574-25-006810 ↗ filed Nov 14, 2025
Holdings Value
Holdings 7 stocks · $1.7B
| MNST Monster Beverage Corp. | 33.59% | 8,250,428 | $555.3M | Reduce -0.1% |
| AXON Axon Enterprise Inc. | 30.10% | 693,504 | $497.7M | Reduce -0.1% |
| STAA Staar Surgical Co. | 21.97% | 13,519,491 | $363.3M | No change |
| IWM iShares Russell 2000 ETF | 6.95% | 474,920 | $114.9M | No change |
| LCTX Lineage Cell Therapeutics Inc. | 5.07% | 49,560,992 | $83.8M | No change |
| IMDX Insight Molecular Diagnostic | 2.29% | 11,410,100 | $37.9M | No change |
| SER Serina Therapeutics Inc. | 0.03% | 83,195 | $446K | Reduce -2.4% |
Options reported separately and not counted above: UAL calls ($4.3M), HBI calls ($1.8M), LUV calls ($714K), AAL calls ($709K), DAL calls ($704K).
Portfolio Sells Q2 2025 → Q3 2025
Portfolio Buys Q2 2025 → Q3 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 6 | $1.9B | MNST, STAA, AXON, IWM, IMDX |
| Q1 2026 | 6 | $1.4B | MNST, STAA, AXON, IWM, LCTX |
| Q4 2025 | 7 | $1.7B | MNST, AXON, STAA, IWM, IMDX |
| Q3 2025 | 7 | $1.7B | MNST, AXON, STAA, IWM, LCTX |
| Q2 2025 | 8 | $1.5B | AXON, MNST, STAA, IWM, LCTX |
| Q1 2025 | 8 | $1.2B | MNST, AXON, STAA, IWM, IMDX |
| Q4 2024 | 7 | $1.3B | MNST, AXON, STAA, IWM, LCTX |
| Q3 2024 | 7 | $1.3B | MNST, STAA, AXON, IWM, LCTX |
| Q2 2024 | 7 | $1.3B | STAA, MNST, AXON, IWM, LCTX |
| Q1 2024 | 7 | $1.3B | MNST, STAA, AXON, IWM, LCTX |